Literature DB >> 29904874

May migraine attack response to triptans be a predictor of the efficacy of Onabotulinum toxin-A prophylaxis?

Carlo Lovati1, Luca Giani2, Caterina Mariotti D Alessandro2, Payam Tabaee Damavandi2, Claudio Mariani2, Leonardo Pantoni2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29904874     DOI： 10.1007/s10072-018-3388-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  3 in total

1.  OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine.

Authors:  Eva Cernuda-Morollón; César Ramón; Pablo Martínez-Camblor; Esther Serrano-Pertierra; Davinia Larrosa; Julio Pascual
Journal:  Pain       Date:  2015-05       Impact factor: 6.961

2.  Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.

Authors:  Ninan T Mathew; Jayasree Kailasam; Lori Meadors
Journal:  Headache       Date:  2007-09-12       Impact factor: 5.887

3.  Effects of OnabotulintoxinA on Habituation of Laser Evoked Responses in Chronic Migraine.

Authors:  Marina de Tommaso; Marianna Delussi; Katia Ricci; Anna Montemurno; Irene Carbone; Eleonora Vecchio
Journal:  Toxins (Basel)       Date:  2016-05-25       Impact factor: 4.546
  3 in total
  1 in total

1.  Association between response to triptans and response to erenumab: real-life data.

Authors:  Ilaria Frattale; Valeria Caponnetto; Alfonsina Casalena; Maurizio Assetta; Maurizio Maddestra; Fabio Marzoli; Giannapia Affaitati; Maria Adele Giamberardino; Stefano Viola; Amleto Gabriele; Francesca Pistoia; Davide Cerone; Carmine Marini; Simona Sacco; Raffaele Ornello
Journal:  J Headache Pain       Date:  2021-01-06       Impact factor: 7.277
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.